Drug Recall
Ongoing
2026 recordClass II
thiamine HCl, 500 mg, 500 mg added to 100 mL, 0.9% Sodium Chloride Injection, USP, Fagron Sterile Services, 20 Dan Road, Canton, MA 02021, NDC 71506-079-56.
by Fresenius Kabi Compounding, LLC
- Reason
- Lack of Assurance of Sterility
- Recall initiated
- February 5, 2026
- Reported by FDA
- February 18, 2026
- Distribution
- US Nationwide.
View recall →
Drug Recall
Ongoing
2026 recordClass II
ketamine HCl, 1,000 mg, 1,000 mg per 100 mL (10 mg per mL) in Sodium Chloride Injection, Fagron Sterile Services, 20 Dan Road, Canton, MA 02021, NDC 71506-050-56
by Fresenius Kabi Compounding, LLC
- Reason
- Lack of Assurance of Sterility
- Recall initiated
- February 5, 2026
- Reported by FDA
- February 18, 2026
- Distribution
- US Nationwide.
View recall →
Drug Recall
Ongoing
2026 recordClass II
acyclovir sodium, 200 mg, 200mg added to 100 mL, 0.9% Sodium Chloride Injection, USP, For Intravenous Use, Single-Use Bag, Fagron Sterile Services, 20 Dan Road, Canton, MA 02021, NDC 71506-035-56
by Fresenius Kabi Compounding, LLC
- Reason
- Lack of Assurance of Sterility
- Recall initiated
- February 5, 2026
- Reported by FDA
- February 18, 2026
- Distribution
- US Nationwide.
View recall →
Drug Recall
Ongoing
2026 recordClass II
Testosterone 100mg Anastrozole 4mg , 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC: 79559-4104-32
by F.H. INVESTMENTS, Inc. (dba Asteria Health)
- Reason
- Presence of Foreign substance - potential presence of metal particulate matter
- Recall initiated
- January 26, 2026
- Reported by FDA
- February 18, 2026
- Distribution
- Nationwide in the USA
View recall →
Drug Recall
Ongoing
2026 recordClass II
Testosterone 87.5mg, Triamcinolone Acetonide17.5 mcg, 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC: 79559-6087-32.
by F.H. INVESTMENTS, Inc. (dba Asteria Health)
- Reason
- Presence of Foreign substance - potential presence of metal particulate matter
- Recall initiated
- January 26, 2026
- Reported by FDA
- February 18, 2026
- Distribution
- Nationwide in the USA
View recall →
Drug Recall
Ongoing
2026 recordClass II
Testosterone 200mg, Triamcinolone Acetonide 40mcg, 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC: 79559-6200-43.
by F.H. INVESTMENTS, Inc. (dba Asteria Health)
- Reason
- Presence of Foreign substance - potential presence of metal particulate matter
- Recall initiated
- January 26, 2026
- Reported by FDA
- February 18, 2026
- Distribution
- Nationwide in the USA
View recall →
Drug Recall
Ongoing
2026 recordClass II
Testosterone 100mg, Triamcinolone Acetonide 20mcg, 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC:79559-6100-32.
by F.H. INVESTMENTS, Inc. (dba Asteria Health)
- Reason
- Presence of Foreign substance - potential presence of metal particulate matter
- Recall initiated
- January 26, 2026
- Reported by FDA
- February 18, 2026
- Distribution
- Nationwide in the USA
View recall →
Drug Recall
Ongoing
2026 recordClass II
Testosterone 75mg, Anastrozole 4mg, 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC: 79559-4079-32.
by F.H. INVESTMENTS, Inc. (dba Asteria Health)
- Reason
- Presence of Foreign substance - potential presence of metal particulate matter
- Recall initiated
- January 26, 2026
- Reported by FDA
- February 18, 2026
- Distribution
- Nationwide in the USA
View recall →
Drug Recall
Ongoing
2026 recordClass II
Testosterone 100mg, Anastrozole 4mg (4.5), 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC: 79559-4104-01.
by F.H. INVESTMENTS, Inc. (dba Asteria Health)
- Reason
- Presence of Foreign substance - potential presence of metal particulate matter
- Recall initiated
- January 26, 2026
- Reported by FDA
- February 18, 2026
- Distribution
- Nationwide in the USA
View recall →
Drug Recall
Ongoing
2026 recordClass II
Testosterone, 303 mg, 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC: 79559-1303-01.
by F.H. INVESTMENTS, Inc. (dba Asteria Health)
- Reason
- Presence of Foreign substance - potential presence of metal particulate matter
- Recall initiated
- January 26, 2026
- Reported by FDA
- February 18, 2026
- Distribution
- Nationwide in the USA
View recall →
Drug Recall
Ongoing
2026 recordClass II
Testosterone, 200 mg, 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC: 79559-1200-43.
by F.H. INVESTMENTS, Inc. (dba Asteria Health)
- Reason
- Presence of Foreign substance - potential presence of metal particulate matter
- Recall initiated
- January 26, 2026
- Reported by FDA
- February 18, 2026
- Distribution
- Nationwide in the USA
View recall →
Drug Recall
Ongoing
2026 recordClass II
Testosterone, 100 mg, 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC:79559-1100-32.
by F.H. INVESTMENTS, Inc. (dba Asteria Health)
- Reason
- Presence of Foreign substance - potential presence of metal particulate matter
- Recall initiated
- January 26, 2026
- Reported by FDA
- February 18, 2026
- Distribution
- Nationwide in the USA
View recall →
Drug Recall
Ongoing
2026 recordClass II
Testosterone, 87.5 mg, 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC: 79559-1087-32.
by F.H. INVESTMENTS, Inc. (dba Asteria Health)
- Reason
- Presence of Foreign substance - potential presence of metal particulate matter
- Recall initiated
- January 26, 2026
- Reported by FDA
- February 18, 2026
- Distribution
- Nationwide in the USA
View recall →
Drug Recall
Ongoing
2026 recordClass II
Testosterone, 62.5 mg, 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC: 79559-1062-32.
by F.H. INVESTMENTS, Inc. (dba Asteria Health)
- Reason
- Presence of Foreign substance - potential presence of metal particulate matter
- Recall initiated
- January 26, 2026
- Reported by FDA
- February 18, 2026
- Distribution
- Nationwide in the USA
View recall →
Drug Recall
Ongoing
2026 recordClass II
Testosterone, 50.0 mg, 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC: 79559-1050-32.
by F.H. INVESTMENTS, Inc. (dba Asteria Health)
- Reason
- Presence of Foreign substance - potential presence of metal particulate matter
- Recall initiated
- January 26, 2026
- Reported by FDA
- February 18, 2026
- Distribution
- Nationwide in the USA
View recall →
Drug Recall
Ongoing
2026 recordClass II
Testosterone, 37.5 mg, 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC: 79559-1037-32.
by F.H. INVESTMENTS, Inc. (dba Asteria Health)
- Reason
- Presence of Foreign substance - potential presence of metal particulate matter
- Recall initiated
- January 26, 2026
- Reported by FDA
- February 18, 2026
- Distribution
- Nationwide in the USA
View recall →
Drug Recall
Ongoing
2026 recordClass II
Testosterone, 25.0 mg, 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC: 79559-1025-32.
by F.H. INVESTMENTS, Inc. (dba Asteria Health)
- Reason
- Presence of Foreign substance - potential presence of metal particulate matter
- Recall initiated
- January 26, 2026
- Reported by FDA
- February 18, 2026
- Distribution
- Nationwide in the USA
View recall →
Drug Recall
Ongoing
2026 recordClass II
Testosterone, 18.0 mg, 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC: 79559-1018-32.
by F.H. INVESTMENTS, Inc. (dba Asteria Health)
- Reason
- Presence of Foreign substance - potential presence of metal particulate matter
- Recall initiated
- January 26, 2026
- Reported by FDA
- February 18, 2026
- Distribution
- Nationwide in the USA
View recall →
Drug Recall
Ongoing
2026 recordClass II
Testosterone, 12.5 mg, 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC: 79559-1012-32.
by F.H. INVESTMENTS, Inc. (dba Asteria Health)
- Reason
- Presence of Foreign substance - potential presence of metal particulate matter
- Recall initiated
- January 26, 2026
- Reported by FDA
- February 18, 2026
- Distribution
- Nationwide in the USA
View recall →
Drug Recall
Ongoing
2026 recordClass II
ESTRADIOL, 37.5 mg, 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC: 79559-3037-32.
by F.H. INVESTMENTS, Inc. (dba Asteria Health)
- Reason
- Presence of Foreign substance - potential presence of metal particulate matter
- Recall initiated
- January 26, 2026
- Reported by FDA
- February 18, 2026
- Distribution
- Nationwide in the USA
View recall →
This information is republished from FDA's Recall Enterprise System through openFDA. Public Health Trace
does not verify or supplement it, is not affiliated with the FDA, and does not provide medical advice --
always follow the guidance of your pharmacist, physician, or the recalling company for any medication you take.
Read the full medical disclaimer.